CZ20012464A3 - Farmaceutický prostředek - Google Patents

Farmaceutický prostředek Download PDF

Info

Publication number
CZ20012464A3
CZ20012464A3 CZ20012464A CZ20012464A CZ20012464A3 CZ 20012464 A3 CZ20012464 A3 CZ 20012464A3 CZ 20012464 A CZ20012464 A CZ 20012464A CZ 20012464 A CZ20012464 A CZ 20012464A CZ 20012464 A3 CZ20012464 A3 CZ 20012464A3
Authority
CZ
Czechia
Prior art keywords
brivudine
magnesium stearate
microcrystalline cellulose
purified water
treatment
Prior art date
Application number
CZ20012464A
Other languages
Czech (cs)
English (en)
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin-Chemie Ag
Menarini Ricerche S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin-Chemie Ag, Menarini Ricerche S. P. A. filed Critical Berlin-Chemie Ag
Publication of CZ20012464A3 publication Critical patent/CZ20012464A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ20012464A 2001-01-03 2001-07-04 Farmaceutický prostředek CZ20012464A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (it) 2001-01-03 2001-01-03 Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera

Publications (1)

Publication Number Publication Date
CZ20012464A3 true CZ20012464A3 (cs) 2002-08-14

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012464A CZ20012464A3 (cs) 2001-01-03 2001-07-04 Farmaceutický prostředek

Country Status (20)

Country Link
AT (1) AT6141U1 (fr)
BE (1) BE1014522A5 (fr)
CH (1) CH695662A5 (fr)
CZ (1) CZ20012464A3 (fr)
DK (1) DK177084B1 (fr)
ES (1) ES2192456B1 (fr)
FI (1) FI20011446A7 (fr)
FR (1) FR2818907B1 (fr)
GB (1) GB2370771A (fr)
GR (1) GR1004012B (fr)
HR (1) HRPK20010345B3 (fr)
HU (1) HUP0102816A3 (fr)
IE (1) IE20010413A1 (fr)
IT (1) ITMI20010009A1 (fr)
NL (1) NL1018431C2 (fr)
PL (1) PL348480A1 (fr)
PT (1) PT102642B (fr)
SE (1) SE0102309L (fr)
SK (1) SK287043B6 (fr)
UA (1) UA76402C2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (es) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez Composicion farmacologica de uso topico para el tratamiento del herpes zoster.
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (fr) * 1982-09-28 1984-04-04 Beecham Group Plc Dérivés de la déoxyuridine, leurs méthodes de préparation et leur emploi en médecine
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
CA2243237C (fr) * 1996-01-19 2008-09-02 Glaxo Group Limited Utilisation de valaciclovir dans la fabrication d'un medicament destine au traitement de l'herpes genital

Also Published As

Publication number Publication date
CH695662A5 (de) 2006-07-31
FI20011446L (fi) 2002-07-04
FR2818907A1 (fr) 2002-07-05
ES2192456B1 (es) 2005-02-01
GB0110682D0 (en) 2001-06-20
HRP20010345A2 (en) 2003-08-31
IE20010413A1 (en) 2003-04-16
PL348480A1 (en) 2002-07-15
AT6141U1 (de) 2003-05-26
HRPK20010345B3 (en) 2005-02-28
FI20011446A7 (fi) 2002-07-04
ITMI20010009A1 (it) 2002-07-03
DK177084B1 (da) 2011-07-11
GR1004012B (el) 2002-11-01
FI20011446A0 (fi) 2001-07-03
GR20010100322A (el) 2002-10-08
FR2818907B1 (fr) 2006-05-26
DK200101019A (da) 2002-07-04
SK9572001A3 (en) 2003-03-04
HUP0102816A3 (en) 2005-01-28
ITMI20010009A0 (it) 2001-01-03
UA76402C2 (en) 2006-08-15
HU0102816D0 (en) 2001-09-28
PT102642A (pt) 2002-07-31
BE1014522A5 (fr) 2003-12-02
ES2192456A1 (es) 2003-10-01
SK287043B6 (sk) 2009-10-07
NL1018431C2 (nl) 2002-07-05
GB2370771A (en) 2002-07-10
PT102642B (pt) 2003-06-30
HUP0102816A2 (en) 2002-10-28
SE0102309D0 (sv) 2001-06-28
SE0102309L (sv) 2002-07-04

Similar Documents

Publication Publication Date Title
US20140275139A1 (en) Mdr method and products for treating hiv/aids
EP1673107B1 (fr) Compositions contenant un agoniste selectif des recepteurs de l'imidazoline et un antagoniste des recepteurs a l'angiotensine ii
KR100709528B1 (ko) 혈당콘트롤용 의약조성물
CZ20012464A3 (cs) Farmaceutický prostředek
US20240041882A1 (en) Mini-tablet dosage form of a viral terminase inhibitor and uses thereof
DK2509586T3 (en) MUCOADHASIVE BUCHALT TABLETS FOR THE TREATMENT OF OROFACIAL HERPES
EP3801532B1 (fr) Préparations de raltégravir
Baker Valacyclovir in the treatment of genital herpes and herpes zoster
US20220370466A1 (en) Regimens for treating hiv infections and aids
US8592434B2 (en) Mucoadhesive buccal tablets for the treatment of orofacial herpes
KR100709531B1 (ko) 당뇨병성 합병증의 예방 또는 진전저지용 의약조성물
EP4403177A1 (fr) Nouveau médicament combiné pour le traitement d'infections à coronavirus, composition pharmaceutique et utilisation associée
RU2842683C1 (ru) Фармацевтическая комбинация осельтамивира, парацетамола, источника витамина с и блокатора гистаминовых рецепторов
SI20854A (sl) Farmacevtska zmes z učinkovino Brivudine z enkratnim dnevnim doziranjem
WO2026052081A1 (fr) Médicaments et combinaisons pour le traitement de l'hépatite b
CN114392239B (zh) 一种拉米夫定、齐多夫定和依非韦伦的复方片及其制备方法
CN114401724B (zh) 一种降糖药物组合物
CN118059049A (zh) 一种制剂组合物及其用途
EA005497B1 (ru) Применение фармацевтической композиции, содержащей бривудин, для лечения герпесвирусных инфекций
WO2023091107A1 (fr) Préparation de nouvelles formulations médicamenteuses capables de présenter un effet antiviral et investigation de leur effet contre la covid-19
CN119997945A (zh) 用于预防或治疗肾病和/或糖尿病的包含依那格列净的药物组合物
RO121585B1 (ro) Utilizarea brivudinei în tratamentul infectiilor de tip herpes zoster sau nevralgiei post-herpetice
HK40091300A (en) Cysteamine for use in anti-viral therapy
HK40091300B (en) Cysteamine for use in anti-viral therapy
HK40048893A (en) Integrase inhibitors for the prevention of hiv